DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Aarti Drugs Limited — Board Meeting Intimation

NSE 1 hr ago·24 Jul 2026, 1:57 pm

Aarti Drugs

Aarti Drugs has announced a board meeting scheduled for July 31, 2026. The primary agenda for this gathering is to review and approve the company's audited financial results for the quarter that ended in June 2026.

This upcoming announcement is a key milestone for the company. Investors will closely watch the report to gauge the firm's quarterly performance and operational health. Any significant deviation from market expectations could impact the stock's short-term movement.

Market participants should monitor the release for details on revenue growth, profit margins, and any commentary on future business outlook. This data will provide clarity on the company's current trajectory ahead of the next trading session.